Google Ventures leads $35M funding round for digital health pharmaceutical company

GV, formerly known as Google Ventures, led a series A $35 million funding round for a digital health pharmaceutical company Waltz Health.

Advertisement

Waltz Health, created by former OptumRx CEO Mark Thierer, is developing software to intervene at each step in the pharmaceutical supply chain to create the incentives necessary for lower drug prices, according to an April 26 press release. 

Waltz’s first product, Marketplace Search, is a white-labeled search tool that gives pharmacy customers the lowest cost available for each prescription by leveraging all Rx drug savings programs.

“We are working with the existing drug supply chain structure to realign incentives, lower prescription drug prices and give power back to healthcare consumers,” said Mr. Thierer. “Our mission begins with giving consumers visibility into available programs to save money on life-saving medications by partnering with their pharmacies.”

Waltz Health plans to use the new funding to scale quickly, invest in product development and grow its team across all business areas.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Digital Health

Advertisement

Comments are closed.